Posted in | News

Centrifugal Field Flow Fractionation Improves Characterization of Drug Delivery Systems

Postnova Analytics reports that its CF2000 Centrifugal Field Flow Fractionation system is delivering exciting new data to scientists developing drug delivery systems.

One of the grand challenges of characterization of any drug delivery system is the determination of cargo mass per delivery vesicle. Size characterization techniques are inherently inadequate to provide such information. By comparison we have found that our CF2000 Centrifugal Field-Flow Fractionation (CF3) system, a mass-based, high resolution separation instrument, is capable of measuring the cargo mass per vesicle to a limit of quantification of 12 attogram (12 x 10-18 g).

Soheyl Tadjiki, Managing Director, Postnova Analytics Inc.

In Centrifugal Field-Flow Fractionation (CF3) the separation force is established by a centrifugal field, which is generated by spinning the complete circular channel at a high rate. The bigger and denser particles are forced more in the direction of the outer wall than the smaller particles. As a consequence, bigger particles are eluted later from the CF3 channel as they are located in slower streamlines in the channel than the smaller particles which are located in faster stream lines.

Based on the CF3 principle, the Postnova CF2000 employs a centrifugal field as the driving force for separations. Particles affected by this field are separated by dynamic diffusion on the basis of both particle size and density. This unique feature of the CF2000 allows the separation of different particulate materials having the same particle size. Separations on the CF2000 can be further optimized by using different eluents and temperature programs. As a consequence, the CF2000 system is proving an ideal tool for the separation and characterization of complex particulate samples in areas including agriculture, cosmetics, nanomaterials and pharmaceutical drug delivery systems.

In contrast to traditional particle sizing techniques which work in the batch mode, the CF3 technique physically separates each particle fraction prior to sizing. This avoids numerous disadvantages of these batch techniques such as, low size resolution, discrimination and under estimation of smaller compared to larger particles. Using Postnova CF3 technology no special sample preparation is necessary as they can be injected directly without filtration, allowing the characterization of even complex particulate materials without alteration and damage.

For further information on the Postnova CF2000 system please visit https://www.postnova.com/product/systems/cf2000-centri-fff.html.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Postnova Analytics. (2020, March 11). Centrifugal Field Flow Fractionation Improves Characterization of Drug Delivery Systems. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=53071.

  • MLA

    Postnova Analytics. "Centrifugal Field Flow Fractionation Improves Characterization of Drug Delivery Systems". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=53071>.

  • Chicago

    Postnova Analytics. "Centrifugal Field Flow Fractionation Improves Characterization of Drug Delivery Systems". AZoM. https://www.azom.com/news.aspx?newsID=53071. (accessed November 21, 2024).

  • Harvard

    Postnova Analytics. 2020. Centrifugal Field Flow Fractionation Improves Characterization of Drug Delivery Systems. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=53071.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.